Kopin Corporation (KOPN) Stock Price & How to Invest

Kopin Corporation has been building miniature displays since 1984, and the core business is unglamorous: liquid crystal and OLED microdisplays, plus the optical lenses and modules built around them, sold into thermal weapon sights, training and simulation rigs, 3D metrology machines and medical headsets. Defense is where the money actually comes from, contributing about $7.3 million of the $7.6 million in product revenue booked in the second quarter of 2026. Three newer lines sit on top of that base. The company is developing full color MicroLED under a U.S. Government Industrial Base Analysis and Sustainment award, aimed at ground soldier vision systems; it has launched Sentinel FPV, a first person view drone product pitched at the U.S. Government's one way attack drone initiative; and through a joint development agreement with Fabric.AI it is working on Neural I/o, a GPU to GPU optical interconnect for AI infrastructure. Kopin also owns a 19.99% stake in Fabric.AI and, since October 2025, has a European defense partner in Theon, which took 49% of subsidiary Kopin Europe for $8.0 million.

The investment picture turns on a gap between the two halves of the revenue line. Total second quarter revenue rose 51% year over year to about $12.7 million, which reads impressively until you separate it: product revenue was roughly $7.6 million, up about 2%, while non product revenue (government grants, funded R&D and collaboration income) went from about $1.0 million to about $5.1 million. Grant and development money is real cash and it validates the technology, but it is program dependent and it does not compound the way product shipments do. Meanwhile the cost of product revenue ran at 86% of product revenue in the quarter and 93% across the first half, so the shipping business is close to breakeven at the gross line. The balance sheet is unlevered, with about $50.3 million of cash, restricted cash and securities against no borrowings, though $25.4 million of that is locked in a supersedeas bond backing a $19.7 million trade secrets judgment now on appeal. At roughly 23 times trailing sales for a company with a $10 million trailing operating loss, the multiple already assumes the MicroLED, drone and interconnect programs convert.

Valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. The growth in the headline revenue line came from grants, funded R&D and collaboration income, which are contract specific and can end when a program phase ends. Litigation remains unresolved: a Colorado jury found for BlueRadios in the trade secrets case and a September 2025 post trial order awarded roughly $19.7 million, which Kopin has accrued, bonded with $23.0 million of restricted cash and appealed to the Federal Circuit, where BlueRadios is cross appealing for additional damages and an injunction that could restrict products incorporating the disputed technology. Separately, Kopin filed a Form NT 10-K on March 27, 2026 citing complex technical accounting considerations before filing its annual report on April 13, and plaintiff firm Johnson Fistel announced an investigation of potential claims on March 31; as of the 10-Q filed August 11, 2026, no securities class action has been filed against the company and its Legal Proceedings note discloses only the BlueRadios matter. Dilution is a standing feature rather than an event, with a 19.5 million share PIPE in September 2025 raising about $38.1 million net and share count now near 179.5 million, and management states liquidity into the fourth quarter of 2027 while continuing to burn cash from operations.

6 analysts publish price targets on KOPN, averaging $8.67 against a $5.50 price as of August 2026, or +57.6%. The published targets run from $6.50 to $12.00, a moderate spread, and the ratings split 6 buy, 0 hold, 0 sell. Over the last six months there have been 4 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full KOPN forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Kopin Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Color MicroLED for the U.S. Army. Kopin's IBAS funded program cleared several thresholds in mid 2026, including single panel full color brightness above 150,000 nits and the installation of U.S. The most optimistic published target, $12.00, assumes this works close to its best case.

The case against. Valuation is the first order risk: about 23 times trailing sales is a demanding multiple for a company whose product revenue grew 2% year over year last quarter and whose cost of product revenue consumed 93% of product sales across the first half of 2026. The most pessimistic target, $6.50, is roughly what KOPN is worth if this bites instead.

Read the full bull and bear case on KOPN, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Kopin Corporation's investor relations page or your broker.

• Revenue (TTM): ~$43.6M
• Q2 2026 total revenue: ~$12.7M, up ~51% year over year
• Q2 2026 product revenue: ~$7.6M, up ~2% year over year
• Operating loss (TTM): ~$10M
• Cash, restricted cash and securities: ~$50.3M, of which ~$25.4M is restricted
• Price to sales (TTM): ~23x

The trailing net income figure of roughly $8.0 million is misleading on its own, because it comes from investment gains, a $2.1 million tax benefit tied to an expiring statute of limitations, and a reduction in the BlueRadios litigation accrual rather than from operations. Strip those out and the business ran an operating loss of about $10 million over the last twelve months on roughly $43.6 million of revenue. Management has guided to a second half exceeding its prior expectations and says it expects meaningful progress toward sustainable GAAP profitability in the fourth quarter of 2026.

Other names that sit close to KOPN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get KOPN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so KOPN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where KOPN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

KOPN prices a 2027 story about soldier displays, drones and optical interconnect, while the trailing statements still show roughly $10 million of operating loss on product margins in the low teens.

Whether KOPN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is KOPN a buy or a sell?, and where the stock could go from here in the KOPN stock forecast.

For income investors, whether KOPN pays a dividend and how the payout looks is covered in does KOPN pay a dividend? And to weigh KOPN against a peer, read the full side-by-side comparisons: KOPN vs SONY and KOPN vs HIMX.